| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702682 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
The expression of VKOR in benign prostate epithelial cells, along with the association between a functional VKOR SNP and prostate cancer risk, suggests a possible role for VKOR in mediating the effect of warfarin on prostate cancer risk. Larger multi-institutional cohort studies are warranted, as are molecular studies on the role of VKOR in prostate cancer development.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ben Yi Ph.D., Sumanta K. M.D., Miaoling B.S., Tommy M.D., Huiqing M.D., JoAnn B.S., Xueli Ph.D., Susan L. Ph.D., Jeremy O. Ph.D.,